Lisa A. Kueltzo

Also affiliated with National Institute of Allergy and Infectious Diseases

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 9 papers. Top paper: “Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial”.

Safety, tolerability, and immunogenicity of the respiratory syncytial virus prefusion F subunit vaccine DS-Cav1: a phase 1, randomised, open-label, dose-escalation clinical trial

The Lancet Respiratory Medicine(2021)10.1016/s2213-2600(21)00098-9

N/A

2.5DataRank · unranked

67 citations

Kaitlyn M. Morabito, Emily Phung, Michelle C. Crank, Pamela Costner, LaSonji A. Holman +74 more

An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults

Science Translational Medicine(2023)10.1126/scitranslmed.ade4790

N/A

1.9DataRank · unranked

96 citations

Amelia R. Hofstetter, Katherine V. Houser, Seemal F. Awan, Grace Chen, Maria Claudia Burgos Florez +95 more

Low-dose intravenous and subcutaneous CIS43LS monoclonal antibody for protection against malaria (VRC 612 Part C): a phase 1, adaptive trial

The Lancet Infectious Diseases(2023)10.1016/s1473-3099(22)00793-9

N/A

1.2DataRank · unranked

41 citations

Andrea A. Berry, Kaitlin Mason, Azza H. Idris, Mark O’Callahan, Myra Happe +95 more

Safety and immunogenicity of a trivalent virus-like particle vaccine against western, eastern, and Venezuelan equine encephalitis viruses: a phase 1, open-label, dose-escalation, randomised clinical trial

The Lancet Infectious Diseases(2022)10.1016/s1473-3099(22)00052-4

N/A

1.1DataRank · unranked

39 citations

Srilatha Edupuganti, Grace Chen, Myra Happe, Larisa Strom, Alicia T. Widge +67 more

Removal of variable domain N -linked glycosylation as a means to improve the homogeneity of HIV-1 broadly neutralizing antibodies

mAbs(2020)10.1080/19420862.2020.1836719

N/A

0.345DataRank · unranked

9 citations

Mangaiarkarasi Asokan, Vera B. Ivleva, Amarendra Pegu, Eun Sung Yang, Baoshan Zhang +14 more

Multi-attribute monitoring (MAM) methodology for glycosylated subunit vaccines

Scientific Reports(2025)10.1038/s41598-025-24922-8

N/A

0DataRank · unranked

0 citations

Lisa M. Jenkins, Nathan Barefoot, Darielys Maldonado, Jeremy J. Wolff, Yanhong Yang +13 more

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen

Scientific Reports(2020)10.1038/s41598-020-59711-y

N/A

0DataRank · unranked

57 citations

Wing‐Pui Kong, Gwo‐Yu Chuang, Mridul Ghosh, Krishana Gulla, Sijy O’Dell +69 more

Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah Vaccine

Frontiers in Immunology(2021)10.3389/fimmu.2021.772864

N/A

0DataRank · unranked

69 citations

Anthony DiPiazza, Samantha Falcone, Tracy J. Ruckwardt, Kaitlyn M. Morabito, Olubukola M. Abiona +14 more

Structure-Based Design of Nipah Virus Vaccines: A Generalizable Approach to Paramyxovirus Immunogen Development

Frontiers in Immunology(2020)10.3389/fimmu.2020.00842

N/A

0DataRank · unranked

87 citations

Guillaume B. E. Stewart-Jones, Yaroslav Tsybovsky, Ria T. Caringal, Kaitlyn M. Morabito, Jason S. McLellan +7 more